Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023
ページ情報: 英文 174 Pages
世界の塞栓保護装置市場規模は、2018年の4億550万米ドルから2023年までに6億490万米ドルに達すると予測され、予測期間中は8.3%のCAGR (年間複合成長率) が見込まれています。心血管・神経血管疾患の発症率の上昇、資金・投資の増加、技術的に進歩した塞栓保護装置の発売、および低侵襲手術に対する需要の拡大は、同市場の成長を促進すると予測されています。しかし、製品の不具合・リコールは市場成長をある程度抑制する見込みです。
The global embolic protection devices market is projected to reach USD 604.9 million by 2023 from USD 405.5 million in 2018, at a CAGR of 8.3% during the forecast period. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. However, product failure and recalls may restrain market growth to a certain extent.
By type, the global embolic protection devices market is segmented into distal filter devices, distal occlusion devices & proximal occlusion devices. By material, the global embolic protection devices market is segmented into plastic nitinol and polyurethane. In 2017, the distal filters segment dominated the embolic protection devices market by type and Nitinol dominated the embolic protection material market.
On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by factors such as growing geriatric population, increasing obese population, increasing prevalence of aortic stenosis in heart patients, and rising demand for minimally invasive procedures.
North America dominated the embolic protection devices market in 2017, followed by Europe. In North America, the US is expected to hold the largest share of the embolic protection devices market due to the rising prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding to develop novel products, and the strong presence of device manufacturers in the country.
Break of primary participants was as mentioned below:
The major players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).
The embolic protection devices market in this report is segmented by type & material, application, indication, end user, and region. It provides detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers, acquisitions, product development, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the embolic protection devices market.
From an insight perspective, this research report focuses on various levels of analysis-market share analysis of top players and company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the embolic protection devices market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest industry statistics and trends, allowing buyers to identify the high-growth product segments, potential customers, and suppliers hence driving revenue growth and profitability.
The report provides insights on the following pointers:
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.